Rosen Law Firm Urges BioVie Inc. Investors to Act Ahead of Class Action Deadline

NEW YORK, Feb. 24, 2024 – Rosen Law Firm, recognized for advocating for the rights of global investors, is calling attention to the shareholders of BioVie Inc. BIVI, a clinical-stage biotechnology company, regarding an impending deadline for a securities class action lawsuit. Investors who purchased BioVie securities during the period from August 5, 2021, to November 29, 2023, are urged to seek legal counsel before the deadline on March 19, 2024, with respect to becoming a lead plaintiff in the lawsuit.

Understanding the Case

The case against BioVie Inc. centers on allegations that the company might have issued materially misleading business information to the investing public. The specified timeframe for these allegations, known as the Class Period, has raised concerns among investors about the accuracy of BioVie's disclosures regarding its financial performance and business prospects.

The Role of Rosen Law Firm

Rosen Law Firm specializes in securities class actions and shareholder derivatives litigation. As a firm that has established a global presence in investor counsel, Rosen Law Firm is facilitating the process for aggrieved BioVie shareholders to join the class action lawsuit. Filing as a lead plaintiff can allow individuals with significant losses from their investment in BioVie to potentially direct the litigation process.

About BioVie Inc.

BioVie Inc., based in Santa Monica, California, focuses on the discovery, development, and commercialization of innovative drug therapies. The company is actively involved in clinical stages of biotechnological research in the United States and aims to deliver novel treatments for various medical conditions.

Marching Towards the Deadline

Investors are reminded that the deadline to apply as a lead plaintiff is swiftly approaching. March 19, 2024, stands as an important cutoff date for any BioVie shareholder who suffered a loss between August 5, 2021, and November 29, 2023, and is interested in taking an active role in the case. Rosen Law Firm emphasizes the importance of a timely response to participate in the class action lawsuit effectively.

deadline, lawsuit, investors